Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Beam Therapeutics Inc. | 10%+ Owner | Common Stock | 2.92M | $77.2M | $26.42 | Jun 30, 2021 | Indirect |
Lyell Immunopharma, Inc. | 10%+ Owner | Common Stock | 18.2M | $41.5M | $2.28 | Jun 21, 2021 | ARCH Venture Fund IX, L.P. |
Lyell Immunopharma, Inc. | 10%+ Owner | Common Stock | 18.2M | $41.5M | $2.28 | Jun 21, 2021 | ARCH Venture Fund IX Overage, L.P. |
Beam Therapeutics Inc. | 10%+ Owner | Common Stock | 28.1K | $743K | $26.42 | Jun 30, 2021 | Direct |
Vir Biotechnology, Inc. | 10%+ Owner | Common Stock | 61.2K | $93.6K | $1.53 | Sep 6, 2022 | Indirect |
Vir Biotechnology, Inc. | 10%+ Owner | Common Stock | 30.6K | $46.8K | $1.53 | Sep 6, 2022 | Direct |
Lyell Immunopharma, Inc. | 10%+ Owner | Series A Convertible Preferred Stock | 0 | Jun 21, 2021 | ARCH Venture Fund IX, L.P. | ||
Lyell Immunopharma, Inc. | 10%+ Owner | Series A Convertible Preferred Stock | 0 | Jun 21, 2021 | ARCH Venture Fund IX Overage, L.P. | ||
Lyell Immunopharma, Inc. | 10%+ Owner | series C Convertible Preferred Stock | 0 | Jun 21, 2021 | ARCH Venture Fund IX, L.P. | ||
Lyell Immunopharma, Inc. | 10%+ Owner | Series C Convertible Preferred Stock | 0 | Jun 21, 2021 | ARCH Venture Fund IX Overage, L.P. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VIR | Vir Biotechnology, Inc. | Sep 2, 2022 | 10 | $0 | 4 | Sep 7, 2022 | 10%+ Owner |
VIR | Vir Biotechnology, Inc. | Aug 30, 2022 | 10 | $0 | 4 | Sep 1, 2022 | 10%+ Owner |
VIR | Vir Biotechnology, Inc. | Aug 24, 2022 | 10 | $0 | 4 | Aug 26, 2022 | 10%+ Owner |
VIR | Vir Biotechnology, Inc. | Aug 18, 2022 | 5 | $0 | 4 | Aug 22, 2022 | 10%+ Owner |
VIR | Vir Biotechnology, Inc. | Aug 12, 2022 | 15 | $0 | 4 | Aug 16, 2022 | 10%+ Owner |
VIR | Vir Biotechnology, Inc. | Jun 8, 2022 | 5 | $0 | 4 | Jun 10, 2022 | 10%+ Owner |
VIR | Vir Biotechnology, Inc. | Jun 2, 2022 | 4 | $0 | 4 | Jun 6, 2022 | 10%+ Owner |
VIR | Vir Biotechnology, Inc. | Dec 20, 2021 | 4 | $0 | 4 | Dec 22, 2021 | 10%+ Owner |
VIR | Vir Biotechnology, Inc. | Nov 29, 2021 | 4 | $0 | 4 | Dec 1, 2021 | 10%+ Owner |
VIR | Vir Biotechnology, Inc. | Nov 22, 2021 | 4 | $0 | 4 | Nov 24, 2021 | 10%+ Owner |
VIR | Vir Biotechnology, Inc. | Jul 1, 2021 | 4 | $0 | 4 | Jul 6, 2021 | 10%+ Owner |
BEAM | Beam Therapeutics Inc. | Jun 30, 2021 | 5 | $0 | 4 | Jul 2, 2021 | 10%+ Owner |
BEAM | Beam Therapeutics Inc. | Jun 25, 2021 | 10 | $0 | 4 | Jun 29, 2021 | 10%+ Owner |
VIR | Vir Biotechnology, Inc. | Jun 22, 2021 | 4 | $0 | 4 | Jun 24, 2021 | 10%+ Owner |
LYEL | Lyell Immunopharma, Inc. | Jun 21, 2021 | 6 | $0 | 4 | Jun 23, 2021 | 10%+ Owner |
LYEL | Lyell Immunopharma, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | 10%+ Owner |